Neogen Current Ratio 2010-2025 | NEOG
Neogen current ratio from 2010 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Neogen Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-02-28 | $0.55B | $0.14B | 3.91 |
| 2024-11-30 | $0.57B | $0.15B | 3.77 |
| 2024-08-31 | $0.54B | $0.12B | 4.41 |
| 2024-05-31 | $0.59B | $0.15B | 3.82 |
| 2024-02-29 | $0.60B | $0.16B | 3.82 |
| 2023-11-30 | $0.62B | $0.18B | 3.54 |
| 2023-08-31 | $0.58B | $0.14B | 4.23 |
| 2023-05-31 | $0.59B | $0.15B | 4.03 |
| 2023-02-28 | $0.56B | $0.11B | 5.18 |
| 2022-11-30 | $0.64B | $0.15B | 4.22 |
| 2022-08-31 | $0.61B | $0.07B | 9.07 |
| 2022-05-31 | $0.63B | $0.08B | 8.05 |
| 2022-02-28 | $0.61B | $0.07B | 9.28 |
| 2021-11-30 | $0.61B | $0.06B | 9.75 |
| 2021-08-31 | $0.61B | $0.05B | 12.00 |
| 2021-05-31 | $0.59B | $0.05B | 11.04 |
| 2021-02-28 | $0.56B | $0.05B | 12.09 |
| 2020-11-30 | $0.58B | $0.05B | 12.97 |
| 2020-08-31 | $0.56B | $0.05B | 11.99 |
| 2020-05-31 | $0.54B | $0.05B | 11.08 |
| 2020-02-29 | $0.52B | $0.04B | 13.16 |
| 2019-11-30 | $0.50B | $0.04B | 12.89 |
| 2019-08-31 | $0.47B | $0.04B | 11.71 |
| 2019-05-31 | $0.45B | $0.04B | 11.75 |
| 2019-02-28 | $0.42B | $0.03B | 12.33 |
| 2018-11-30 | $0.41B | $0.04B | 10.69 |
| 2018-08-31 | $0.40B | $0.04B | 10.10 |
| 2018-05-31 | $0.38B | $0.04B | 9.71 |
| 2018-02-28 | $0.35B | $0.04B | 9.44 |
| 2017-11-30 | $0.34B | $0.04B | 8.96 |
| 2017-08-31 | $0.31B | $0.04B | 8.11 |
| 2017-05-31 | $0.29B | $0.04B | 8.14 |
| 2017-02-28 | $0.28B | $0.04B | 7.97 |
| 2016-11-30 | $0.29B | $0.03B | 8.52 |
| 2016-08-31 | $0.27B | $0.03B | 8.23 |
| 2016-05-31 | $0.25B | $0.03B | 8.68 |
| 2016-02-29 | $0.26B | $0.03B | 9.18 |
| 2015-11-30 | $0.25B | $0.03B | 8.02 |
| 2015-08-31 | $0.24B | $0.03B | 8.75 |
| 2015-05-31 | $0.23B | $0.03B | 9.08 |
| 2015-02-28 | $0.22B | $0.03B | 8.19 |
| 2014-11-30 | $0.21B | $0.02B | 8.53 |
| 2014-08-31 | $0.20B | $0.02B | 8.22 |
| 2014-05-31 | $0.19B | $0.03B | 7.56 |
| 2014-02-28 | $0.18B | $0.03B | 7.17 |
| 2013-11-30 | $0.18B | $0.02B | 7.68 |
| 2013-08-31 | $0.18B | $0.02B | 7.79 |
| 2013-05-31 | $0.17B | $0.02B | 9.51 |
| 2013-02-28 | $0.16B | $0.02B | 7.09 |
| 2012-11-30 | $0.15B | $0.02B | 8.33 |
| 2012-08-31 | $0.15B | $0.02B | 8.05 |
| 2012-05-31 | $0.14B | $0.02B | 7.21 |
| 2012-02-29 | $0.14B | $0.02B | 7.81 |
| 2011-11-30 | $0.13B | $0.02B | 7.08 |
| 2011-08-31 | $0.12B | $0.02B | 6.81 |
| 2011-05-31 | $0.12B | $0.02B | 6.88 |
| 2011-02-28 | $0.11B | $0.02B | 5.57 |
| 2010-11-30 | $0.11B | $0.02B | 5.08 |
| 2010-08-31 | $0.10B | $0.02B | 4.90 |
| 2010-05-31 | $0.09B | $0.02B | 5.05 |
| 2010-02-28 | $0.09B | $0.02B | 6.15 |
| 2009-11-30 | $0.09B | $0.02B | 6.08 |
| 2009-08-31 | $0.08B | $0.01B | 6.55 |
| 2009-05-31 | $0.07B | $0.01B | 7.76 |
| 2009-02-28 | $0.07B | $0.01B | 6.26 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.035B | $0.924B |
| Neogen Corp. develops and markets food and animal safety products. Its Food Safety Division markets culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen has 2 business segments: Food Safety and Animal Safety. Food Safety: The products in the segment include tests for Mycotoxins, Food allergens, Dairy antibiotics, Foodborne pathogens, Spoilage microorganisms, Sanitation monitoring, Dehydrated culture media and Seafood contaminants. Animal Safety: The division is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides and genomics testing services for the worldwide animal safety market. These products are marketed via national & international distributors and farm supply retail chains in the U.S. and Canada. It acquired Delta Genomics Centre in Canada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.851B | 27.88 |
| Boston Scientific (BSX) | United States | $151.436B | 37.91 |
| Stryker (SYK) | United States | $144.721B | 30.26 |
| EssilorLuxottica (ESLOY) | France | $129.653B | 0.00 |
| Medtronic (MDT) | Ireland | $110.247B | 15.63 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.183B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.171B | 26.90 |
| ResMed (RMD) | United States | $37.320B | 28.03 |
| Agilent Technologies (A) | United States | $32.988B | 21.51 |
| GE HealthCare Technologies (GEHC) | United States | $32.583B | 15.47 |
| Terumo (TRUMY) | Japan | $26.976B | 35.04 |
| Koninklijke Philips (PHG) | Netherlands | $21.839B | 15.32 |
| Insulet (PODD) | United States | $21.652B | 84.99 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.103B | 11.63 |
| Baxter (BAX) | United States | $15.390B | 11.49 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.776B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.410B | 22.31 |
| Lantheus Holdings (LNTH) | United States | $5.591B | 14.10 |
| Prestige Consumer Healthcare (PBH) | United States | $4.170B | 18.63 |
| Perrigo (PRGO) | Ireland | $3.636B | 9.22 |
| Haemonetics (HAE) | United States | $3.462B | 15.77 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.203B | 26.62 |
| ICU Medical (ICUI) | United States | $3.152B | 23.24 |
| GN Store Nord (GNNDY) | Denmark | $2.272B | 18.82 |
| LeMaitre Vascular (LMAT) | United States | $1.884B | 42.11 |
| QuidelOrtho (QDEL) | United States | $1.870B | 12.86 |
| AtriCure (ATRC) | United States | $1.579B | 0.00 |
| Acuren (TIC) | United States | $1.283B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.120B | 11.37 |
| Green Thumb Industries (GTBIF) | United States | $1.018B | 22.91 |
| BioLife Solutions (BLFS) | United States | $1.015B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.991B | 12.67 |
| InMode (INMD) | Israel | $0.853B | 8.59 |
| Kestra Medical Technologies (KMTS) | United States | $0.822B | 0.00 |
| CeriBell (CBLL) | United States | $0.668B | 0.00 |
| Evolus (EOLS) | United States | $0.605B | 0.00 |
| Owens & Minor (OMI) | United States | $0.562B | 4.67 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.537B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.514B | 0.00 |
| Valneva SE (VALN) | France | $0.476B | 0.00 |
| Surmodics (SRDX) | United States | $0.415B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.363B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.351B | 0.00 |
| SNDL (SNDL) | Canada | $0.326B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.323B | 11.86 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.307B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.287B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.264B | 22.23 |
| Cerus (CERS) | United States | $0.256B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.247B | 0.00 |
| Quanterix (QTRX) | United States | $0.245B | 0.00 |
| ZimVie (ZIMV) | United States | $0.241B | 10.95 |
| OraSure Technologies (OSUR) | United States | $0.227B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.222B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.220B | 65.17 |
| Biote (BTMD) | United States | $0.219B | 6.17 |
| Canopy Growth (CGC) | Canada | $0.219B | 0.00 |
| Brainsway (BWAY) | Israel | $0.217B | 57.45 |
| TriSalus Life Sciences (TLSI) | United States | $0.200B | 0.00 |
| Omeros (OMER) | United States | $0.187B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.178B | 14.52 |
| Verano Holdings (VRNOF) | United States | $0.177B | 0.00 |
| High Tide (HITI) | Canada | $0.175B | 0.00 |
| Organigram Global (OGI) | Canada | $0.171B | 0.00 |
| Exagen (XGN) | United States | $0.148B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.131B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.122B | 15.02 |
| Jin Medical (ZJYL) | China | $0.101B | 0.00 |
| Veru (VERU) | United States | $0.091B | 0.00 |
| Fonar (FONR) | United States | $0.088B | 11.29 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.086B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.084B | 0.00 |
| MacroGenics (MGNX) | United States | $0.083B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.079B | 0.00 |
| Apyx Medical (APYX) | United States | $0.076B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.076B | 0.00 |
| Zynex (ZYXI) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Agape ATP (ATPC) | $0.069B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.054B | 0.00 |
| Nephros (NEPH) | United States | $0.045B | 61.29 |
| Modular Medical (MODD) | United States | $0.042B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.03 |
| Rockwell Medical (RMTI) | United States | $0.030B | 0.00 |
| Safety Shot (SHOT) | United States | $0.025B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| Senestech (SNES) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |